EDN1 and hypertensive disorder: Circulating ET-1 levels have been observed in patients with diffuse SSc with widespread fibrosis and those with limited SSc and hypertensive disease [11], suggesting that soluble ET-1 levels may be a marker of fibrosis and vascular damage.